RESULTS	SPORTIF III ( open label , n = 3410 ) and V ( double-blind , n = 3922 ) included 2257 women with AF and one or more stroke risk factors randomized to warfarin [ target international normalized ratio ( INR ) 2.0-3 .0 ] or ximelagatran ( 36 mg twice daily ) .\